Beijing Tiantan Biological Products Co., Ltd. (600161.SS)
CNY 20.69
(-1.0%)
CNY 20.69
(-1.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.42 Billion | 1.12 Billion | 980.35 Million | 702.1 Million | 642.46 Million | 677.91 Million |
| Net Income | 1.1 Billion | 1.2 Billion | 1.06 Billion | 943.07 Million | 894.25 Million | 735.89 Million |
| Depreciation & Amortization | 284.52 Million | 179.74 Million | 157.15 Million | 132.75 Million | 128.2 Million | 130.01 Million |
| Deferred income taxes | 11.86 Million | 883.77 Thousand | -7.66 Million | -7.86 Million | -29.89 Million | -16.58 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 613.6 Million | -234.24 Million | -261.76 Million | -386.05 Million | -390.57 Million | -193.9 Million |
| Other non-cash items | 362.89 Million | -24.33 Million | 16.14 Million | 12.33 Million | 10.58 Million | 5.91 Million |
| Investing Cash Flow | -1.28 Billion | -1.87 Billion | -2.18 Billion | -620.46 Million | -565.81 Million | -317.59 Million |
| Investments in PPE | -1.07 Billion | -1.35 Billion | -1.13 Billion | -608.9 Million | -526.22 Million | -293.9 Million |
| Acquisitions | -1.26 Million | -36.35 Million | -29.49 Million | 609.81 Thousand | -30.34 Million | 285.72 Thousand |
| Investment purchases | -1.7 Billion | -1.5 Billion | -30 Million | -15 Million | -25 Million | -30 Million |
| Sales/Maturities of investments | 1.5 Billion | 22.5 Million | 8.51 Million | 5.14 Million | 213.4 Thousand | 275 Thousand |
| Other Investing Activities | -1.85 Million | 996.97 Million | -1 Billion | -2.31 Million | 15.54 Million | 5.74 Million |
| Financing Cash Flow | -508.08 Million | -378.2 Million | 2.77 Billion | 254.16 Million | 86.87 Million | -1.03 Billion |
| Debt repayment | -366.25 Million | -107.5 Million | -326.25 Million | -400 Million | -169.21 Million | -540 Million |
| Dividends payments | -82.39 Million | -137.31 Million | -137.31 Million | -62.72 Million | -43.55 Million | -140.13 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -59.44 Million | -113.48 Million | 3.26 Billion | 747.05 Million | 316.44 Million | -351.35 Million |
| Accounts receivables | 1.02 Billion | -221.04 Million | -351.2 Million | -82.48 Million | -217.08 Million | -95.11 Million |
| Accounts payables | 98.57 Million | 167.41 Million | 66.15 Million | -73.05 Million | 97.71 Million | 44.71 Million |
| Inventory | -514.44 Million | -181.49 Million | 30.95 Million | -222.65 Million | -241.3 Million | -126.91 Million |
| Other working capital | 110.43 Million | 883.77 Thousand | -7.66 Million | -7.86 Million | -29.89 Million | -66.99 Million |
| Cash at beginning of period | 2.19 Billion | 3.31 Billion | 1.74 Billion | 1.41 Billion | 1.24 Billion | 1.91 Billion |
| Cash at end of period | 2.83 Billion | 2.19 Billion | 3.31 Billion | 1.74 Billion | 1.41 Billion | 1.24 Billion |
| Capital Expenditure | -1.07 Billion | -1.35 Billion | -1.13 Billion | -608.9 Million | -526.22 Million | -293.9 Million |
| Effect of forex changes on cash | -325.19 | -47.91 Thousand | -11.04 Thousand | -217.58 Thousand | -550.42 Thousand | 3.34 Million |
| Net cash flow / Change in cash | 638.59 Million | -1.12 Billion | 1.56 Billion | 335.58 Million | 162.97 Million | -667.82 Million |
| Free Cash Flow | 1.34 Billion | -228.01 Million | -151.34 Million | 93.2 Million | 116.23 Million | 384.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 325.63 Million | 409.41 Million | 316.67 Million | 1.1 Billion | 222.48 Million | 320.6 Million |
| Depreciation & Amortization | - | 84.66 Million | 84.66 Million | 284.52 Million | 77.02 Million | -126.22 Million |
| Deferred income taxes | - | - | - | 11.86 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -320.16 Million | - | 613.6 Million | 515.03 Million | -272.12 Million |
| Other non-cash items | -233.62 Million | 434.67 Million | 152.14 Million | 362.89 Million | -247.07 Million | 1.14 Billion |
| Investing Cash Flow | -192.62 Million | 729.86 Million | -783.21 Million | -1.28 Billion | -346.87 Million | -253.34 Million |
| Investments in PPE | -186.03 Million | -270.14 Million | -278.09 Million | -1.07 Billion | -347.08 Million | -249.99 Million |
| Acquisitions | 83.12 Thousand | 5263.00 | -5.11 Million | -1.26 Million | 212.14 Thousand | -1.49 Million |
| Investment purchases | 500 Million | -500 Million | - | -1.7 Billion | -1.7 Billion | 1.7 Billion |
| Sales/Maturities of investments | 25.33 Million | 1 Billion | - | 1.5 Billion | 1.5 Billion | -1.5 Billion |
| Other Investing Activities | -31.91 Million | 500 Million | -500 Million | -1.85 Million | 200 Million | -201.85 Million |
| Financing Cash Flow | -8.09 Million | -356.18 Million | -2.01 Million | -508.08 Million | -221.15 Million | -216.06 Million |
| Debt repayment | - | - | - | -366.25 Million | -184.59 Million | -125.4 Million |
| Dividends payments | - | -247.17 Million | - | -82.39 Million | -82.39 Million | -85.01 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.09 Million | -101.96 Million | -2.01 Million | -59.44 Million | 45.83 Million | -5.64 Million |
| Accounts receivables | - | -26.55 Million | - | 1.02 Billion | 1.02 Billion | -259.02 Million |
| Accounts payables | - | - | - | 98.57 Million | - | - |
| Inventory | - | -293.6 Million | - | -514.44 Million | -514.44 Million | -13.09 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.64 Billion | 4.74 Billion | 2.83 Billion | 2.19 Billion | 5.06 Billion | 2.74 Billion |
| Cash at end of period | 3.54 Billion | 3.65 Billion | 4.74 Billion | 2.83 Billion | 2.83 Billion | 3.34 Billion |
| Capital Expenditure | -186.03 Million | -270.14 Million | -278.09 Million | -1.07 Billion | -347.08 Million | -249.99 Million |
| Effect of forex changes on cash | -77.68 Thousand | 14.21 Thousand | 1075.03 | -325.19 | -3151.17 | -10.53 Thousand |
| Net cash flow / Change in cash | -108.78 Million | -1.09 Billion | 1.91 Billion | 638.59 Million | -2.22 Billion | 599.83 Million |
| Free Cash Flow | -94.02 Million | 489.27 Million | 190.72 Million | 1.34 Billion | -294.64 Million | 819.25 Million |
STMRF
FBLG
605388
SCANFL
TM
BOWFF